Clinical Trials Directory

Trials / Unknown

UnknownNCT04000412

A Novel Myocardial Impedance Mapping System for Ablation of Post-infarction Ventricular Arrhytmias in Humans

Status
Unknown
Phase
Study type
Observational
Enrollment
25 (estimated)
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Precise identification of the infarct scar is essential for successful catheter ablation of ventricular arrhythmias in patients with chronic myocardial infarction. Voltage mapping of endocardial electrograms is currently used to delineate the necrotic scar but this is influenced by the direction of the activation wave front and is not sensitive enough to differentiate distinct degrees of transmural injury in the scar. Mapping of local myocardial electrical impedance may overcome these limitations.

Detailed description

Clinical series: Patients with chronic infarction undergoing catheter ablation of ventricular arrhythmias will be submitted to mapping of both voltage and tissue impedance. Likewise, the accuracy of the two maps identifying the extent and transmurality of the infarction will be assesssed by gadolinium imaging. The impedance system is already constructed and certified for clinical research use.

Conditions

Interventions

TypeNameDescription
DEVICECardioZ multifrequency impedance recording systemPatients will be submitted to mapping of both voltage and tissue impedance. The accuracy of the two maps identifying the extent and transmurality of the infarction will be assesssed by gadolinium imaging.

Timeline

Start date
2019-03-19
Primary completion
2022-02-04
Completion
2022-02-25
First posted
2019-06-27
Last updated
2019-06-27

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04000412. Inclusion in this directory is not an endorsement.